Relationship of Serum Uric Acid with Kidney Function Decline Mediated by Systemic Arterial Stiffness: A Retrospective Cohort Study in Japan

Daiji Nagayama,Yasuhiro Watanabe,Kentaro Fujishiro,Kenji Suzuki,Kohji Shirai,Atsuhito Saiki
DOI: https://doi.org/10.3390/diagnostics14020195
IF: 3.6
2024-01-17
Diagnostics
Abstract:Hyperuricemia is associated with kidney function decline (KFD), although whether hyperuricemia directly causes nephrotoxicity or is indirectly mediated by systemic arterial stiffening remains unclear. We examined the detailed relationship of serum uric acid (SUA) with KFD and potential mediation by arterial stiffness. Study population was 27,648 urban residents with an estimated glomerular filtration rate (eGFR) of ≥60 mL/min/1.73 m2 at baseline, and they participated in a median of three consecutive annual health examinations. Arterial stiffness was assessed using cardio-ankle vascular index (CAVI). KFD was defined as a decrease in eGFR to below 60. Multivariate analysis showed an association between baseline SUA and CAVI independent of eGFR. During the study period, 6.6% of participants developed KFD. Stratified analysis revealed a linear relationship between the contribution of CAVI or SUA and KFD. ROC analysis determined a cutoff CAVI of 8.0 (males) or 7.9 (females) and a cutoff SUA of 6.3 (males) or 4.5 mg/dL (females) for predicting KFD. The linkage between SUA and CAVI was associated with a greater increase in the hazard ratio for KFD with an increase in SUA. CAVI showed the mediating effect on the relationship of SUA with KFD after an adjustment for confounders. SUA was associated positively with CAVI-mediated KFD. Further studies should verify whether intensive SUA-lowering treatment prevents KFD via improving vascular function.
medicine, general & internal
What problem does this paper attempt to address?
This paper attempts to address the issue of exploring the relationship between serum uric acid (SUA) and kidney function decline (KFD), and whether this relationship is mediated by systemic arterial stiffness. Specifically, the study aims to elucidate in detail the association between the cardio-ankle vascular index (CAVI) and SUA with KFD, and to investigate the mediating role of CAVI in the relationship between SUA and KFD. ### Main Research Questions: 1. **Relationship between SUA and KFD**: Investigate whether SUA levels are associated with the occurrence of KFD. 2. **Mediating Role of CAVI**: Explore whether CAVI mediates the relationship between SUA and KFD. 3. **Combined Effect of SUA and CAVI**: Analyze how the combined effect of SUA and CAVI influences the risk of KFD. ### Research Background: - Hyperuricemia is associated with kidney function decline, but its mechanism is unclear, potentially causing direct nephrotoxicity or indirectly affecting through systemic arterial stiffness. - Arterial stiffness parameters (such as CAVI) reflect vascular function and are significant for the assessment and treatment of cardiovascular metabolic diseases. - Previous studies have shown that CAVI is related to kidney function indicators (such as estimated glomerular filtration rate eGFR) and can more effectively predict KFD. ### Research Methods: - **Study Design**: Retrospective cohort study using data from the cardiovascular disease and cancer screening project organized by the Japan Health Promotion Foundation. - **Study Subjects**: 27,648 Japanese urban residents with normal kidney function at baseline, who participated in 2 to 8 consecutive annual health check-ups. - **Data Collection**: Including demographic characteristics, blood pressure, blood glucose, blood lipids, uric acid, eGFR, and other indicators. - **Statistical Analysis**: Using multivariable linear regression, Cox proportional hazards model, ROC curve analysis, and mediation analysis. ### Main Findings: - **Baseline Characteristics**: Participants in the KFD group were older, had a higher proportion of males, higher BMI, higher CAVI, higher blood pressure, higher blood glucose, more dyslipidemia, more proteinuria, and higher treatment frequencies for hypertension, diabetes, hyperlipidemia, and gout/hyperuricemia. - **Relationship between SUA and CAVI**: Baseline SUA was positively correlated with CAVI independent of eGFR. - **Risk Factors for KFD**: SUA and CAVI were independently and positively associated with the risk of KFD. - **Combined Effect**: The combined effect of SUA and CAVI significantly increased the risk of KFD. - **Mediation Analysis**: CAVI partially mediated the relationship between SUA and KFD (mediation rate 7.3%). ### Conclusion: - The study confirms that SUA indirectly affects kidney function decline through systemic arterial stiffness. - CAVI can serve as a useful indicator for assessing and monitoring nephrotoxicity caused by hyperuricemia. - Future research needs to further verify whether lowering SUA can prevent KFD by improving vascular function. This study provides a new perspective for understanding the complex relationship between hyperuricemia and kidney function decline and offers potential biomarkers for clinical treatment.